Zoledronic acid prevents bone loss in early-stage breast cancer

被引:0
|
作者
Francesco Bertoldo
Giuseppe Tonini
Bruno Vincenzi
Daniele Santini
机构
[1] University of Verona,
[2] University Campus Bio-Medico,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of zoledronic acid probably extends for some years after cessation of therapy.
引用
收藏
页码:191 / 192
页数:1
相关论文
共 50 条
  • [31] The incidence of bone metastasis after early-stage breast cancer in Canada
    Liede, Alexander
    Jerzak, Katarzyna J.
    Hernandez, Rohini K.
    Wade, Sally W.
    Sun, Ping
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 587 - 595
  • [32] Devil's Wake: Early-stage bone colonization by breast cancer
    Wang, Hai
    Yu, Cuijuan
    Zhang, Xiang H. F.
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (03):
  • [33] Evaluation of circulating biomarkers of bone metastases in early-stage breast cancer
    Dean-Colomb, Windy Marie
    Hess, Kenneth R.
    Young, Elliana J.
    Gornet, Terrie
    Handy, Beverly Carol
    Moulder, Stacy L.
    Ibrahim, Nuhad K.
    Pusztai, Lajos
    Booser, Daniel J.
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [34] The incidence of bone metastasis after early-stage breast cancer in Canada
    Alexander Liede
    Katarzyna J. Jerzak
    Rohini K. Hernandez
    Sally W. Wade
    Ping Sun
    Steven A. Narod
    [J]. Breast Cancer Research and Treatment, 2016, 156 : 587 - 595
  • [35] Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury
    J. S. Bubbear
    A. Gall
    F. R. I. Middleton
    M. Ferguson-Pell
    R. Swaminathan
    R. W. Keen
    [J]. Osteoporosis International, 2011, 22 : 271 - 279
  • [36] Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury
    Bubbear, J. S.
    Gall, A.
    Middleton, F. R. I.
    Ferguson-Pell, M.
    Swaminathan, R.
    Keen, R. W.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (01) : 271 - 279
  • [37] Denosumab in early-stage breast cancer
    Rodriguez, Elena Gonzalez
    Aubry-Rozier, Berengere
    Stoll, Delphine
    Lamy, Olivier
    [J]. LANCET ONCOLOGY, 2019, 20 (05): : E233 - E233
  • [38] Obesity and early-stage breast cancer
    Chlebowski, RT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1345 - 1347
  • [39] MEDICAL ONCOLOGY Zoledronic acid for breast cancer therapy-induced bone loss
    Amir, Eitan
    Ocana, Alberto
    Seruga, Bostjan
    Josse, Robert
    Clemons, Mark
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (04) : 187 - 188
  • [40] Effect of zoledronic acid on bone loss in women undergoing chemotherapy for breast cancer.
    Aft R
    Chavez-MacGregor M
    Trinkaus K
    Naughton M
    Weilbaecher K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S38 - S38